Luke Timmerman and Team Kilimanjaro
Curing cancer one mountain at a time.
Biotech journalist Luke Timmerman and Team Kilimanjaro raise $1.1 million for cancer research at Fred Hutch.
Event Details
Congratulations Team Kili!
The Kilimanjaro Climb to Fight Cancer Team, led by Seattle writer and entrepreneur Luke Timmerman, successfully reached the summit of Mt. Kilimanjaro on February 17. Through their hard work, these climbers brought together 1,600 donors, including 23 sponsors, to raise more than $1.1 million for Fred Hutch.
To make a donation, select the name of the climber you would like to support or send your gift to the address below. Be sure to include the name of the climber you are supporting. For stock donations or wire transfer instructions, please email climb@fredhutch.org.
Fred Hutchinson Cancer Center
Attn: Climb to Fight Cancer
1100 Fairview Ave. N., Mail Stop J5-200
Seattle, WA 98109
Meet the Team
- Ram Aiyar, CEO, Korro Bio
- Jonathan Bricker, professor and director, Health and Behavioral Innovations in Technology Lab, Cancer Prevention Program, Fred Hutchinson Cancer Center
- Bharatt Chowrira, president, Puretech Health
- Ginger Cooper, Robot Princess, Artificial, Inc.
- Jens Eckstein, managing partner, Apollo Health Ventures
- Saul Fink, SVP, pharmaceutical & nonclinical development, Normunity
- Brian Gallagher Jr., biotech investor and entrepreneur
- Laurie Halloran, founder and CEO, Halloran Consulting Group
- Amber Kaplan, consultant, Amber Lab LLC, MBA candidate USC Marshall School of Business
- Jak Knowles, co-founder, president and CEO, Affini-T Therapeutics
- Nerissa Kreher, chief medical officer, Entrada Therapeutics
- Jeff Leek, vice president, chief data officer, professor; Fred Hutchinson Cancer Center
- Amanda Murphy, VP, Head of External Innovation and M&A, Ginkgo Bioworks
- Wendy Nelson, president and founder, Boston Biotech Forum; corporate development Danforth Advisors
- Kamal Puri, CSO, OncoResponse
- Andrew Sandford, president, Elevate Bio BaseCamp
- Joanne Smith-Farrell, CEO, Be Biopharma
- Luke Timmerman, founder and editor, Timmerman Report
- Nathan Trinklein, co-founder and CSO, Rondo Therapeutics
- Clint Valentine, vice president of data science, TwinStrand Biosciences
- Ramani Varanasi, managing director, ReVive Advisors
2023 Sponsors
Trek Sponsors
Base Camp Sponsors
Agilent Technologies
Alexandria Real Estate Equities
Alloy Therapeutics
ARCH Venture Partners
Axiom Healthcare Strategies
Bisciotti Foundation
Canaan
Chaplin Partners
Development Insights
Exact Sciences
Ge Li & Ning Zhao Family Foundation
iQ Biosciences
Latham & Watkins LLP
The Linus Group
PureTech
Stifel
Timmerman Traverse Alumni
Vertex Pharmaceuticals
We Can Rise
Team Timmerman Gallery